Battaglia PJ, Kaeser MA, Kettner NW Diagnosis and serial sonography of a proximal fifth metatarsal stress fracture. J Chiropr Med. 2013 Sep;12(3):196-200. doi: 10.1016/j.jcm.2013.10.002.
Bennell KL, Malcolm SA, Thomas SA, Wark JD, Brukner PD The incidence and distribution of stress fractures in competitive track and field athletes. A twelve-month prospective study. Am J Sports Med. 1996 Mar-Apr;24(2):211-7.
Brudvig TJ, Gudger TD, Obermeyer L Stress fractures in 295 trainees: a one-year study of incidence as related to age, sex, and race. Mil Med. 1983 Aug;148(8):666-7.
Khy V, Wyssa B, Bianchi S Bilateral stress fracture of the tibia diagnosed by ultrasound. A case report. J Ultrasound. 2012 Jun;15(2):130-4. doi: 10.1016/j.jus.2011.09.002. Epub 2011 Sep 16.
Liong SY, Whitehouse RW Lower extremity and pelvic stress fractures in athletes. Br J Radiol. 2012 Aug;85(1016):1148-56. doi: 10.1259/bjr/78510315. Review.
Moran DS, Evans RK, Hadad E Imaging of lower extremity stress fracture injuries. Sports Med. 2008;38(4):345-56. Review.
Nitz AJ, Scoville CR Use of ultrasound in early detection of stress fractures of the medial tibial plateau. Mil Med. 1980 Dec;145(12):844-6.
Uri Farkash et al Ultrasonography as a diagnostic modality of tibial stress fractures. J Musculoskelet Res. 11, 55 (2008).
Wright AA, Hegedus EJ, Lenchik L, Kuhn KJ, Santiago L, Smoliga JM Diagnostic Accuracy of Various Imaging Modalities for Suspected Lower Extremity Stress Fractures: A Systematic Review With Evidence-Based Recommendations for Clinical Practice. Am J Sports Med. 2016 Jan;44(1):255-63. doi: 10.1177/0363546515574066. Epub 2015 Mar 24. Review.
Comparison of Ultrasound and X-ray as Screening Tests for Diagnosis of Lower Extremity Stress Fracture
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.